Tech Company Financing Transactions
Vivodyne Funding Round
Vivodyne, based in Philadelphia, secured $38 million from Khosla Ventures, Bison Ventures and CS Venture Opportunities Fund.
Transaction Overview
Company Name
Announced On
11/22/2023
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Seed
Investors
Proceeds Purpose
The funding will advance Vivodyne's discovery pipeline and clinically predictive AI stack, which identifies novel therapeutic targets and predicts patient responses to new drugs by testing directly on lab-grown human organ tissues.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3401 Grays Ferry Ave. 117
Philadelphia, PA 19146
USA
Philadelphia, PA 19146
USA
Phone
Undisclosed
Website
Email Address
Overview
Vivodyne's Pipeline V accelerates the development of cures to human diseases. Experiment on thousands of lab-grown human tissues and dissect biological complexity with superhuman AI. Vivodyne's platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrei Georgescu
Chief Scientific Officer
Daniel Huh
Browse more venture capital transactions:
Prev: 11/22/2023: Relay Technology venture capital transaction
Next: 11/22/2023: Osium AI venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs